PathWhiz ID | Pathway | Meta Data |
---|---|---|
PW109254View Pathway |
protein
Cadmium Induces DNA Synthesis and Proliferation in MacrophagesBos taurus
Cadmium (Cd(2+)) exposure increases the risk of cancer in humans and animals. Humans may come into contact with cadmium when smoking and ingesting contaminated food. This will increase the risk of lung cancer and prostate cancer. In the millimolar range, cadmium will inhibit cell growth. Cadmium induces DNA synthesis and proliferation and affects signal transduction and mobilization in macrophages. At micromolar concentrations, cadmium significantly increased cell division as judged by thymidine uptake and cell counts. Activating this pathway will increase the availability of the transcription factor NF(kappa)B and will activate the early genes c-fos and c-myc.
|
Creator: Ana Marcu Created On: August 31, 2018 at 12:41 Last Updated: August 31, 2018 at 12:41 |
PW109282View Pathway |
protein
Cadmium Induces DNA Synthesis and Proliferation in MacrophagesRattus norvegicus
Cadmium (Cd(2+)) exposure increases the risk of cancer in humans and animals. Humans may come into contact with cadmium when smoking and ingesting contaminated food. This will increase the risk of lung cancer and prostate cancer. In the millimolar range, cadmium will inhibit cell growth. Cadmium induces DNA synthesis and proliferation and affects signal transduction and mobilization in macrophages. At micromolar concentrations, cadmium significantly increased cell division as judged by thymidine uptake and cell counts. Activating this pathway will increase the availability of the transcription factor NF(kappa)B and will activate the early genes c-fos and c-myc.
|
Creator: Ana Marcu Created On: August 31, 2018 at 12:49 Last Updated: August 31, 2018 at 12:49 |
PW109207View Pathway |
protein
Cadmium Induces DNA Synthesis and Proliferation in MacrophagesMus musculus
Cadmium (Cd(2+)) exposure increases the risk of cancer in humans and animals. Humans may come into contact with cadmium when smoking and ingesting contaminated food. This will increase the risk of lung cancer and prostate cancer. In the millimolar range, cadmium will inhibit cell growth. Cadmium induces DNA synthesis and proliferation and affects signal transduction and mobilization in macrophages. At micromolar concentrations, cadmium significantly increased cell division as judged by thymidine uptake and cell counts. Activating this pathway will increase the availability of the transcription factor NF(kappa)B and will activate the early genes c-fos and c-myc.
|
Creator: Ana Marcu Created On: August 31, 2018 at 12:33 Last Updated: August 31, 2018 at 12:33 |
PW124249View Pathway |
Cadena Transportadora y Fosforilación Oxidativa (CV)Homo sapiens
Complejos transportadores de electrones (I, II, III y IV) para la generación de gradiente de protones en la mitocondria y fosforilación oxidativa para generar energía (ATP) mediante ATP sintasa.
|
Creator: Valeria Created On: October 18, 2020 at 22:02 Last Updated: October 18, 2020 at 22:02 |
PW124248View Pathway |
Cadena transportadora de electrones y fosforilación oxidativa (CV) errorHomo sapiens
Complejos transportadores de electrones (I, II, III y IV) para la generación de gradiente de protones en la mitocondria y fosforilación oxidativa para generar energía (ATP) mediante ATP sintasa.
|
Creator: Valeria Created On: October 18, 2020 at 21:57 Last Updated: October 18, 2020 at 21:57 |
PW175987View Pathway |
Cabozantinib Predicted Metabolism Pathway newHomo sapiens
Metabolites of Cabozantinib are predicted with biotransformer.
|
Creator: Omolola Created On: November 29, 2023 at 13:02 Last Updated: November 29, 2023 at 13:02 |
PW145863View Pathway |
drug action
Cabozantinib Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 16:50 Last Updated: October 07, 2023 at 16:50 |
PW128518View Pathway |
drug action
Cabozantinib Action PathwayHomo sapiens
Cabozantinib is a tyrosine kinase inhibitor with broad applications in oncology. Originally approved in 2012 under the brand name Cometriq, it was primarily indicated for metastatic medullary thyroid cancer. Subsequently, a capsule formulation known as Cabometyx gained approval for the treatment of advanced renal cell carcinoma in 2016. In 2019, this same formulation received additional approvals for the treatment of hepatocellular carcinoma in patients who had previously been treated with sorafenib. Cabozantinib's mechanism of action involves inhibiting various receptor tyrosine kinases, effectively suppressing processes such as metastasis, angiogenesis, and oncogenesis, making it a versatile therapeutic option in the management of advanced cancers.
|
Creator: Dorsa Yahya Rayat Created On: September 01, 2023 at 12:22 Last Updated: September 01, 2023 at 12:22 |
PW146443View Pathway |
drug action
Cabotegravir Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 18:12 Last Updated: October 07, 2023 at 18:12 |
PW127486View Pathway |
drug action
Cabotegravir Action PathwayHomo sapiens
Cabotegravir is an HIV-1 integrase inhibitor used for treatment and pre-exposure prophylaxis of HIV-1 infection. It is prescribed with the non-nucleoside reverse transcriptase inhibitor, rilpivirine.
Cabotegravir is transported into the infected cell then transported into the nucleus via importin nuclear transporter. The viral RNA is injected into the cell then transcribed into viral DNA via reverse transcriptase. It is then transported into the nucleus where it is integrated into the host DNA. Cabotegravir inhibits HIV integrase which prevents the viral DNA from being integrated into the host DNA. This prevents viral replication and further progression of the virus. It is used in combination with reverse transcriptase inhibitors which further prevents viral replication and progression of the virus.
|
Creator: Ray Kruger Created On: March 15, 2023 at 14:27 Last Updated: March 15, 2023 at 14:27 |